Ingen Technologies Inc (IGNT)

[stockmasterflash]

SIML was intended al along to sell IGNT stock

Since the global lock on IGNT was lifted, I looked at their last filing. Lookey what they disclosed, that they were intending all along to do a R/M with SIML since SIML DID NOT have a global lock.

***

The wholly owned subsidiary, Ingen Technologies, Inc. (the “Nevada Corporation”) is primarily engaged in the business of respiratory medical device manufacturing. This company owns various assets, inclusive of intellectual property consisting of trademarks, patents, technical designs and inventory, respectively. The company holds the manufacturing and marketing platforms to produce its core medical product line referred to as “Oxyview™” and “Smart Nasal Cannula™”. The company intends to continue to manufacture and distribute its products directly to the consumer upon adequate capitalization, while it seeks to perform a merger with RJM & Associates; a broadcast equipment manufacturer based in Northern California providing a variety of broadcast products for Direct TV, CBS, NBC, FOX and other major broadcast companies. Please refer to rjmandassociates.com/

https://www.otcmarkets.com/financialReportViewer?symbol=IGNT&id=149668

Plan of Operation
As of November 30, 2015, the company continues in evaluating new opportunities. There are two opportunities on our plate at this time. The first opportunity involves recent discussions with a European Company to acquire our Oxyview™ property, and those discussions are still in negotiations. To date, the company has signed a Non-Disclosure Agreement and provided intellectual property documents for the transfer of property. The Netherlands based European Company is in the business of medical supplies for oxygen based health care services. They are highly interested in acquiring the intellectual property and manufacturing processes to manufacture and distribute Oxyview™ in Europe. They are currently evaluating and testing their markets on the idea. The second opportunity is the acquisition of an equipment manufacturer of Broadcasting products in California. The Broadcast Company currently has clients such as Direct TV and FOX; and have placed their broadcast products with over 50 major broadcast agencies, including CBS, NBC, ESPN and ABC.
The above opportunities are explorative and the company anticipates a merger with the Broadcasting Manufacturer, and a transfer of the Medical IP to the Netherlands Company. Management has determined that these changes would be in the best interests of its shareholders. Implemented with these changes would be a corporate name change, new symbols and a restructure of its shares and management.
Until the above opportunities are executed, Ingen continues to sell its core medical Oxyview products, and is capable of manufacturing new inventory if the opportunity arises.